当前位置: 首页 > 期刊 > 《中西医结合心血管病》 > 201817
编号:13579449
影响PRF临床疗效的相关因素(2)
http://www.100md.com 2018年6月15日 《中西医结合心血管病电子杂志》 201817
     [2]毛俊丽,王 拓,孙 勇,等.PRF的制备及保存方法的研究进展[J].西南国防医药,2016(03):326-327.

    [3]Dohan D M,Choukroun J,Diss A,et al.Platelet-rich fibrin (PRF): a second-generation platelet concentrate.Part I: technological concepts and evolution[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2006,101(3):e37-e44.

    [4]Ghanaati S,Booms P,Orlowska A,et al.Advanced Platelet-Rich Fibrin: A New Concept for Cell-Based Tissue Engineering by Means of Inflammatory Cells[J].Journal of Oral Implantology, 2014,40(6):679-689.

    [5]Wang X,Zhang Y,Choukroun J,et al.Behavior of Gingival Fibroblasts on Titanium Implant Surfaces in Combination with either Injectable-PRF or PRP[J].Int J Mol Sci, 2017,18(2).

    [6]Fujioka-Kobayashi M, Miron R J, Hernandez M,et al.Optimized Platelet-Rich Fibrin With the Low-Speed Concept:Growth Factor Release,Biocompatibility,and Cellular Response[J].J Periodontol,2017,88(1):112-121.

    [7]李 龍,赵建辉,刘 斌,等.富血小板纤维蛋白体外释放VEGF影响因素的探讨[J].中国美容医学,2012(03):427-430.

    [8]李艳秋,周延民,孙晓琳,等.富血小板纤维蛋白体外释放TGF-β和PDGF-AB影响因素的探讨[J].现代口腔医学杂志,2012(06):404-407.

    本文编辑:吴 卫, 百拇医药(辛酉凤 赵金)
上一页1 2